Detalhe da pesquisa
1.
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.
Cancers (Basel)
; 14(17)2022 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077801
2.
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265.
Cancers (Basel)
; 14(24)2022 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551754
3.
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety.
J Med Chem
; 64(9): 5404-5428, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33844533